IPO registrations (S-1, F-1) · Registrants
BNB PLUS CORP.
- SEC CIK
- 744452 · filings on EDGAR ↗
- Former names
- APPLIED DNA SCIENCES INC (2002–2025); PROHEALTH MEDICAL TECHNOLOGIES INC (2001–2002); DCC ACQUISITION CORP (1999–2001); DATALINK CAPITAL CORP/TX/ (1998–1999)
- Registration
- Form S-1, first filed 2008-04-21, last 2026-08-05; 10 initial registrations, 18 amendments
- Outcome
- Final prospectus filed 2014-11-18; declared effective 2008-07-24; withdrawal requested 2026-10-01
- Industry (SIC)
- Finance Services 6199
- Incorporated in
- DE
- Business address
- 25 HEALTH SCIENCES DRIVE, Stony Brook, NY
- EIN
- 59-2262718
- Ticker
- BNBX (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- BNB PLUS CORP. on the corporate pages
Offering terms
- Final price
- $3.24 per share (424B4 filed 2014-11-18)
- Listing
- Nasdaq under the symbol APDN
- Lead underwriters
- Maxim Group
- Syndicate
- Dawson James; Years Ended September 30, Nine Months Ended June 30 (2,013); Research and development (692,480); Depreciation and amortization (321,074)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: DATALINK CAPITAL CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: BNB PLUS CORP. Fuzzy (name and state)
- Federal award recipient: BNB PLUS CORP. Fuzzy (name and state)
- Form D issuer: BNB PLUS CORP. EXACT (CIK (EXACT))
- SEC filer: APPLIED DNA SCIENCES INC EXACT (CIK (EXACT))
- Person page: Dr James A Hayward Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
Filings 57
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-04-21 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001188112-08-001354 ↗ |
| 2008-06-16 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001188112-08-001911 ↗ |
| 2008-07-22 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001188112-08-002206 ↗ |
| 2008-07-24 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-08-002286 ↗ |
| 2008-08-22 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001188112-08-002447 ↗ |
| 2008-11-06 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001188112-08-003065 ↗ |
| 2008-11-10 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-08-003341 ↗ |
| 2009-02-23 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-09-000456 ↗ |
| 2009-04-27 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001188112-09-001026 ↗ |
| 2009-05-12 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-09-001383 ↗ |
| 2013-01-04 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-13-000130 ↗ |
| 2013-07-31 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-13-002285 ↗ |
| 2014-10-02 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001571049-14-004906 ↗ |
| 2014-10-30 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001571049-14-005563 ↗ |
| 2014-10-31 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001571049-14-005659 ↗ |
| 2014-11-12 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001571049-14-006173 ↗ |
| 2014-11-14 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-14-003366 ↗ |
| 2014-11-18 | 424B4 | 424B4 (final prospectus) | APPLIED DNA SCIENCES INC | 0001571049-14-006594 ↗ |
| 2015-03-10 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-15-000563 ↗ |
| 2016-12-13 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-16-006443 ↗ |
| 2017-05-26 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-17-001395 ↗ |
| 2017-10-02 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-17-002524 ↗ |
| 2019-09-18 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001144204-19-045086 ↗ |
| 2019-10-25 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-19-056543 ↗ |
| 2019-11-01 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-19-059046 ↗ |
| 2019-11-08 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-19-061616 ↗ |
| 2019-11-13 | S-1MEF | S-1MEF (added securities) | APPLIED DNA SCIENCES INC | 0001104659-19-062966 ↗ |
| 2019-11-13 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-19-002562 ↗ |
| 2019-11-14 | 424B4 | 424B4 (final prospectus) | APPLIED DNA SCIENCES INC | 0001104659-19-063576 ↗ |
| 2020-06-01 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-20-001305 ↗ |
| 2021-02-02 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-21-000394 ↗ |
| 2022-07-19 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001104659-22-080864 ↗ |
| 2022-07-27 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-22-002182 ↗ |
| 2022-08-01 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-22-084740 ↗ |
| 2022-08-04 | S-1MEF | S-1MEF (added securities) | APPLIED DNA SCIENCES INC | 0001104659-22-085934 ↗ |
| 2022-08-04 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-22-002257 ↗ |
| 2022-08-08 | 424B4 | 424B4 (final prospectus) | APPLIED DNA SCIENCES INC | 0001104659-22-086832 ↗ |
| 2022-08-08 | 424B4 | 424B4 (final prospectus) | APPLIED DNA SCIENCES INC | 0001104659-22-086945 ↗ |
| 2023-06-06 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-23-001651 ↗ |
| 2024-03-12 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001104659-24-033115 ↗ |
| 2024-03-15 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-24-035062 ↗ |
| 2024-03-20 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-24-000693 ↗ |
| 2024-04-24 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001104659-24-050738 ↗ |
| 2024-05-15 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-24-061374 ↗ |
| 2024-05-21 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-24-063761 ↗ |
| 2024-05-22 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-24-064286 ↗ |
| 2024-05-24 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-24-065129 ↗ |
| 2024-05-28 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-24-001658 ↗ |
| 2024-05-29 | 424B4 | 424B4 (final prospectus) | APPLIED DNA SCIENCES INC | 0001104659-24-065715 ↗ |
| 2024-11-19 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001104659-24-120259 ↗ |
| 2025-01-10 | S-1/A | S-1/A (amendment) | APPLIED DNA SCIENCES INC | 0001104659-25-002521 ↗ |
| 2025-01-17 | EFFECT | EFFECT (declared effective) | APPLIED DNA SCIENCES INC | 9999999995-25-000138 ↗ |
| 2025-10-30 | S-1 | S-1 (registration) | APPLIED DNA SCIENCES INC | 0001104659-25-103871 ↗ |
| 2025-12-22 | S-1/A | S-1/A (amendment) | BNB PLUS CORP. | 0001104659-25-123402 ↗ |
| 2025-12-29 | EFFECT | EFFECT (declared effective) | BNB PLUS CORP. | 9999999995-25-003933 ↗ |
| 2026-08-05 | S-1 | S-1 (registration) | BNB PLUS CORP. | 0001104659-26-091228 ↗ |
| 2026-10-01 | RW | RW (withdrawal request) | BNB PLUS CORP. | 0001104659-26-112588 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-11-12 | S-1/A | registration statement | - | - | Nasdaq APDN | 2 | primary document; cover names 2 | document ↗ | ||
| 2014-11-18 | 424B4 | final prospectus | $3.24 | - | - | Nasdaq APDN | 5 | primary document; price sentence, underwriting table 3, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Hayward James A | Director,Officer; Director,Officer,TenPercentOwner | Chairman, CEO and President; Chairman, CEO, and President; Chief Executive Officer | 20 | 2006–2021 | person page Fuzzy |
| Simon Sanford R | Director | 13 | 2006–2023 | ||
| SHAMASH YACOV | Director | 2 | 2006 | ||
| Bitzer John III | Director | 16 | 2014–2021 | ||
| Gray Karol | Officer | Chief Financial Officer | 2 | 2014 | |
| Liang Ming-Hwa Benjamin | Officer | Secretary and CSO; Strategic Tech. Dev. Officer | 5 | 2014–2016 | |
| Murrah Judith | Director; Officer | Chief Information Officer; CIO and COO | 18 | 2014–2026 | |
| Ryan Charles S. | Director | 8 | 2014–2019 | ||
| SHAMASH YACOV A | Director | 16 | 2014–2026 | ||
| Ceccoli Joseph D. | Director | 12 | 2014–2026 | ||
| Jantzen Beth | Officer | Chief Financial Officer | 15 | 2015–2025 | |
| CATELL ROBERT B | Director | 13 | 2016–2026 | ||
| Ferguson Elizabeth M. | Director | 11 | 2017–2025 | ||
| Montgomery William W | Other; TenPercentOwner | 16 | 2018–2020 | ||
| Anchin Scott L | Director | 8 | 2019–2023 | ||
| Shorrock Clay | Officer | Chief Executive Officer; Chief Legal Officer | 5 | 2021–2025 | |
| Kruger Joshua | Director; Director,Other | 2 | 2025–2026 | ||
| Haft James | Director | 3 | 2026 | ||
| KGPLA Holdings LLC | TenPercentOwner | 1 | 2026 | ||
| Larsen Todd | Director | 2 | 2026 | ||
| Lee Lok | Director | 2 | 2026 | ||
| Shorten Richard Lee Jr. | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-06-03 | BNB PLUS CORP. | Other | $5,000,000 | $2,500,000 | 1 | 1 |
| 2025-10-15 | APPLIED DNA SCIENCES INC | Biotechnology | $58,000,000 | $58,000,000 | 33 | 1 |
| 2024-11-06 | APPLIED DNA SCIENCES INC | Biotechnology | $13,325,000 | $0 | 8 | 1 |
| 2024-02-12 | APPLIED DNA SCIENCES INC | Biotechnology | $6,874,466 | $0 | 3 | 1 |
| 2020-10-20 | APPLIED DNA SCIENCES INC | Biotechnology | $3,690,830 | $1,198,860 | 2 | 1 |
| 2019-08-26 | APPLIED DNA SCIENCES INC | Biotechnology | $418,000 | $418,000 | 5 | 1 |
| 2019-07-19 | APPLIED DNA SCIENCES INC | Biotechnology | $1,500,000 | $1,500,000 | 1 | 1 |
| 2018-09-04 | APPLIED DNA SCIENCES INC | Biotechnology | $3,500,000 | $1,650,000 | 11 | 1 |
| 2017-07-05 | APPLIED DNA SCIENCES INC | Biotechnology | $1,805,000 | $805,000 | 13 | 1 |
| 2016-11-14 | APPLIED DNA SCIENCES INC | Biotechnology | $5,000,000 | $5,000,000 | 2 | 1 |
| 2015-12-07 | APPLIED DNA SCIENCES INC | Biotechnology | $5,400,000 | $25,000 | 7 | 1 |
| 2014-09-26 | APPLIED DNA SCIENCES INC | Biotechnology | $1,800,000 | $1,800,000 | 2 | 1 |
| 2014-06-17 | APPLIED DNA SCIENCES INC | Biotechnology | $2,145,956 | $2,145,956 | 22 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BNB PLUS CORP. | NY | State business registries | name and state |
| Business registration | DATALINK CAPITAL CORPORATION | TX | State business registries | EIN (EXACT, as the state registration reports it) |
| Federal award recipient | BNB PLUS CORP. | NY | Federal spending (USAspending) | name and state |
| Form D issuer | BNB PLUS CORP. | NY | Form D private offerings | CIK (EXACT) |
| SEC filer | BNB PLUS CORP. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Dr James A Hayward | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Finance Services, NY first:
- OFFITBANK HOLDINGS INC NY
- Lazard Group Finance LLC NY
- Tiptree Financial Partners, L.P. NY
- MAP FINANCIAL GROUP, INC. NY
- LOANIO, INC. NY
- Chaince Digital Holdings Inc. NY
- CAPSTONE FINANCIAL GROUP, INC. NY
- TAO Synergies Inc. NY
- Easterly Acquisition Corp. NY
- Coinbase Global, Inc. NY
In other datasets, the same topic (Finance) in NY:
- Lobbying client: 3B1 PARTNERS (Federal lobbying (LDA))
Interests: Finance Services · Finance